Paper Details

  1. Home
  2. Paper Details

Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.

Author: HanKuem Sun, ParkSeong-Hi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A review of 14 studies found that the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) has high predictive validity as a screening tool for both mild cognitive impairment (MCI) and Alzheimer's disease (AD). The ADAS-Cog demonstrated better diagnostic performance in patients with AD.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Mild cognitive impairment (MCI) and Alzheimer's disease (AD) are screened to distinguish whether the cognitive decline in older adults is attributed to pathological causes rather than normal aging. OBJECTIVE: The purpose of this review was to analyze the diagnostic performance of the Al...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2174/1567205019666220404104854

データ提供：米国国立医学図書館（NLM）

The Desert of Cognitive Decline: Navigating the Path to Diagnosis

Mild cognitive impairment (MCI) and Alzheimer's disease (AD) are conditions that affect cognitive function, often leaving individuals struggling with memory and thinking skills. This study ventures into the desert of cognitive decline, examining the diagnostic performance of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in screening for MCI and AD. The researchers conducted a systematic review, evaluating the sensitivity, specificity, and area under the curve (AUC) of ADAS-Cog. Their findings demonstrate the high predictive validity of ADAS-Cog as a screening tool for both MCI and AD.

ADAS-Cog: A Beacon of Hope in the Desert of Cognitive Decline

The study highlights the effectiveness of ADAS-Cog as a screening tool for MCI and AD. This research provides valuable insights for healthcare providers, empowering them to identify individuals at risk for these conditions and initiate appropriate interventions.

Navigating the Desert of Cognitive Health: A Compass for Early Detection

The study emphasizes the importance of early detection and intervention in MCI and AD. This research empowers individuals to be proactive about their cognitive health, seeking professional evaluation if they experience any concerns.

Dr. Camel's Conclusion

This study demonstrates the high predictive validity of ADAS-Cog as a screening tool for MCI and AD. The research underscores the importance of early detection and intervention in these conditions, providing valuable insights for both healthcare providers and individuals seeking to maintain their cognitive health.

Date :
  1. Date Completed 2022-07-19
  2. Date Revised 2022-07-28
Further Info :

Pubmed ID

35379127

DOI: Digital Object Identifier

10.2174/1567205019666220404104854

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.